跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL
Approved
THERAPEUTIC
MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL
ACS DOBFAR S.P.A. (PRIMARY AND SECONDARY PACKAGING) - ITALYACS DOBFAR SPA 2: ADDETTA SITE (DP INTERMEDIATE) (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
May 4, 2016
Approval ID
1b6065468eeb22a8
Company
ACS DOBFAR S.P.A. (PRIMARY AND SECONDARY PACKAGING) - ITALYACS DOBFAR SPA 2: ADDETTA SITE (DP INTERMEDIATE) (ITALY)
Type
Therapeutic
Approval Details
Approval Id
1b6065468eeb22a8
Drug Name
MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL
Product Name
MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL
Approval Number
SIN15002P
Approval Date
2016-05-04
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DH02
Atc Item Name
meropenem
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Meropenem Trihydrate 570mg equivalent to anhydrous Meropenem
500mg/vial
MEROPENEM TRIHYDRATE 570 MG EQUIVALENT TO ANHYDROUS MEROPENEM
500 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 4, 2016
Approval ID
1b6065468eeb22a8
Type
Therapeutic
Back to HSA Approvals